G. Winckelmann et al., SCHNITZLERS SYNDROME AS CAUSE OF RECURREN T FEVER OF UNKNOWN ORIGIN, Deutsche Medizinische Wochenschrift, 121(27), 1996, pp. 860-864
History and clinical findings: For 4 years a 56-year-old woman had bee
n suffering from chronic urticaria, In the past two years she had deve
loped recurrent fever, each 1-3 days in duration. In the last 6 to 8 m
onths she also had severe aching in the legs. There were no significan
t findings on physical examination other than non-itching urticarial r
ash over trunk and limbs. Investigations: Blood sedimentation rate was
increased (maximum 88/110 mm), as were WBC count (16,200/mu l, 83% ne
utrophils) and the activity of alkaline leucocyte phosphatase (225 U/l
). Monoclonal IgM gammopathy type kappa and circulating IgM immune com
plex (15.4 mg/dl) were demonstrated in serum. Skin biopsy of a new urt
icarial lesion revealed vasculitis. Iliac crest biopsy was unremarkabl
e and showed no lymphoid cell infiltration. Bone scintigraphy revealed
bilaterally increased storage in femor and tibia. Magnetic resonance
imaging demonstrated marrow infiltration without space-occupying featu
res in the affected femur and tibia. Treatment and course: Conjunction
of fever, generalised urticaria, joint/bone pain and monoclonal gammo
pathy of kappa type having established the diagnosis of Schnitzler's s
yndrome, treatment with ibuprofen was started (initially 1,200 mg dail
y by mouth, followed by reduction to 600 mg daily). All symptoms rapid
ly improved and the bone changes regressed, but not the monoclonal gam
mopathy. But when the ibuprofen dosage had been decreased to 600 mg da
ily, the urticaria recurred, though in milder form. Conclusion: This c
ase demonstrates the efficacy of ibuprofen in the treatment of the Sch
nitzler's syndrome. Furthermore reversibility of scintigraphic bone le
sions could be demonstrated under ibuprofen treatment.